Who has invested in Versanis Bio?

Atlas Venture, Medicxi, Aditum Bio are named among the investors backing Versanis Bio.

Versanis Bio Funding: $70M Raised, Series A (2021)

Versanis Bio funding overview

Versanis Bio is based in New York, NY. Versanis Bio has raised $70M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in August 2021. The round record for Versanis Bio runs through 2021; nothing later has been disclosed. Investors on record include Atlas Venture, Medicxi, Aditum Bio. 3 distinct backers are named across the disclosed rounds.

Versanis Bio at a glance

Total raised: $70M
Latest round: Series A
Latest round date: August 2021
Headquarters: New York, NY
Notable investors: Atlas Venture, Medicxi, Aditum Bio

Frequently asked about Versanis Bio funding

How much has Versanis Bio raised?: Versanis Bio has raised $70M in total disclosed funding across the rounds on record.
Who has invested in Versanis Bio?: Atlas Venture, Medicxi, Aditum Bio are named among the investors backing Versanis Bio.
What was the latest Versanis Bio funding round?: The most recent disclosed round is a Series A, announced in August 2021.
Where is Versanis Bio based?: Versanis Bio is based in New York, NY.
When did Versanis Bio last raise?: The last disclosed Versanis Bio round closed in August 2021 at Series A.

Round data for Versanis Bio is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in New York and backer lists below.

Versanis Bio Funding: $70M Raised, Series A (2021)

Versanis Bio funding overview

Versanis Bio at a glance

Frequently asked about Versanis Bio funding

Companies related to Versanis Bio (36)

Browse related funding lists (7)